PMID- 28903127
OWN - NLM
STAT- MEDLINE
DCOM- 20180308
LR  - 20180308
IS  - 1944-7884 (Electronic)
IS  - 1525-4135 (Linking)
VI  - 76
IP  - 2
DP  - 2017 Oct 1
TI  - Considerations for Using the HIRI-MSM Screening Tool to Identify MSM Who Would
      Benefit Most From PrEP.
PG  - e58-e61
LID - 10.1097/QAI.0000000000001472 [doi]
FAU - Wilton, James
AU  - Wilton J
AD  - *Applied Epidemiology Unit, Ontario HIV Treatment Network, Toronto, Ontario,
      CanadadaggerDivision of Infectious Diseases, St. Michael's Hospital, Toronto,
      Ontario, Canadadouble daggerDepartment of Medicine, University of Toronto,
      Toronto, Ontario, Canada.
FAU - Mishra, Sharmistha
AU  - Mishra S
FAU - Tan, Darrell H S
AU  - Tan DHS
LA  - eng
GR  - 136630-1/CIHR/Canada
GR  - 143266-1/CIHR/Canada
PT  - Letter
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - J Acquir Immune Defic Syndr
JT  - Journal of acquired immune deficiency syndromes (1999)
JID - 100892005
RN  - 0 (Anti-HIV Agents)
SB  - IM
SB  - X
MH  - Adult
MH  - Anti-HIV Agents/economics
MH  - Cost-Benefit Analysis
MH  - *Decision Support Systems, Clinical/economics/utilization
MH  - HIV Infections/*prevention & control
MH  - *Homosexuality, Male
MH  - Humans
MH  - Male
MH  - Mass Screening/*methods
MH  - Patient Selection
MH  - Practice Guidelines as Topic
MH  - *Pre-Exposure Prophylaxis/economics/utilization
EDAT- 2017/09/14 06:00
MHDA- 2018/03/09 06:00
CRDT- 2017/09/14 06:00
PHST- 2017/09/14 06:00 [entrez]
PHST- 2017/09/14 06:00 [pubmed]
PHST- 2018/03/09 06:00 [medline]
AID - 10.1097/QAI.0000000000001472 [doi]
AID - 00126334-201710010-00019 [pii]
PST - ppublish
SO  - J Acquir Immune Defic Syndr. 2017 Oct 1;76(2):e58-e61. doi:
      10.1097/QAI.0000000000001472.